The goal of this clinical trial is to learn about the safety and recommended dose of TRI-611 when administered to adults with ALK-positive non-small cell lung …

ALK-positive NSCLCALK-Positive Lung CancerALK-positive Non-small Cell Lung Cancer

~Estimated

~$10 – $8,750

TRIANA Biomedicines, Inc.NCT07491497

Observational

Patient-centered, Optimal Integration of Survivorship and Palliative Care

The goal of this study is to develop and test the feasibility of a supportive care model (POISE) for patients with metastatic Non-small Cell Lung Cancer (NSCLC…

Stage IV Non-small Cell Lung CancerTargeted TherapyNonsmall Cell Lung Cancer+5 more

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT04900935